Hinova Pharmaceuticals (SHSE:688302) FCF Margin %: -74.40% (As of Mar. 2026)


SHSE:688302 Hinova Pharmaceuticals Inc SHSE:688302
26 GF Score
Price ¥33.06
! 2 Warning Signs
View Full Analysis

What is Hinova Pharmaceuticals FCF Margin %?

Hinova Pharmaceuticals SHSE:688302 -5.22% 26 FCF Margin % is -74.40% as of Mar. 2026. GuruFocus rates SHSE:688302 with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 958 Biotechnology companies, Hinova Pharmaceuticals ranks worse than 65.76% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hinova Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was ¥-19.36 Mil. Hinova Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was ¥26.03 Mil. Therefore, Hinova Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -74.40%.

As of today, Hinova Pharmaceuticals's current FCF Yield % is -4.56%.

The historical rank and industry rank for Hinova Pharmaceuticals's FCF Margin % or its related term are showing as below:

SHSE:688302' s FCF Margin % Range Over the Past 10 Years
Min: -75376.84   Med: -1953.25   Max: -320.92
Current: -320.92

During the past 8 years, the highest FCF Margin % of Hinova Pharmaceuticals was -320.92%. The lowest was -75376.84%. And the median was -1953.25%.

SHSE:688302's FCF Margin % is ranked worse than
65.76% of 958 companies
in the Biotechnology industry
Industry Median: -85.21 vs SHSE:688302: -320.92

Hinova Pharmaceuticals FCF Margin % Related Terms

Hinova Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Hinova Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hinova Pharmaceuticals FCF Margin % Chart

Hinova Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 -23,266.57 0.00 -75,376.84 -936.81

Hinova Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -205.17 -472.18 1,899.41 -74.40

SHSE:688302 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Hinova Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hinova Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hinova Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hinova Pharmaceuticals's FCF Margin % falls into.


SHSE:688302
26GF Score
Hinova Pharmaceuticals Inc SHSE:688302
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hinova Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hinova Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-191.764/20.47
=-936.81 %

Hinova Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-19.362/26.025
=-74.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -74.40% mean?
Hinova Pharmaceuticals (SHSE:688302) has a FCF Margin % of -74.40% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hinova Pharmaceuticals and its competitors. According to the industry distribution chart, Hinova Pharmaceuticals ranks #630 out of 958 companies in the Biotechnology industry, placing it in the top 65.8%.
Is Hinova Pharmaceuticals' FCF Margin % too high?
Hinova Pharmaceuticals' current FCF Margin % is -74.40%. Based on the distribution chart, Hinova Pharmaceuticals ranks #630 out of 958 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Hinova Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Hinova Pharmaceuticals' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hinova Pharmaceuticals ranks #630 out of 958 companies for FCF Margin %. This places Hinova Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hinova Pharmaceuticals and its competitors. Hinova Pharmaceuticals's current FCF Margin % is -74.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hinova Pharmaceuticals stock overvalued right now?
Hinova Pharmaceuticals (SHSE:688302) has a current FCF Margin % of -74.40%. The current FCF Margin % is -74.40%. Hinova Pharmaceuticals' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hinova Pharmaceuticals (SHSE:688302), the current FCF Margin % is -74.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hinova Pharmaceuticals Business Description

Address No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041
Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.
26GF Score

Get the complete analysis for SHSE:688302

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥33.06
Price